Xin Zhang

Xin Zhang

Auto-generated profile, based on publicly available information

Xin Zhang

Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
KDKe Deng
Ke Deng
XZXin Zhang
Xin Zhang
YLYing Liu
Ying Liu
LZLi Zhang
Li Zhang
GWGang Wang
Gang Wang
PGpeter gibson
peter gibson

1 August 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
JSJiang Shao
Jiang Shao
XZXin Zhang
Xin Zhang
WZWang Zhan
Wang Zhan
YZYuehong Zheng
Yuehong Zheng
BLBao Liu
Bao Liu
Type IIIb endoleak is a rare complication after endovascular aneurysm repair (EVAR) and the understanding of type IIIb endoleak is insufficient. Three elderly patients with previously successfully performed EVARs were sent to our center due to abdominal pain and diagnosed with late type IIIb endoleak. The type IIIb endoleak fabric tears were closed with cuffs or stents by endovascular retreatment. The patients recovered adequately and were discharged from hospital. Endovascular repair with empirical relining could be a good choice for treatment of late type IIIb endoleak with good prognosis.

29 June 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
XZXin Zhang
Xin Zhang
Purpose: Extrapulmonary small cell carcinoma (EPSCC) is rare, and its knowledge is mainly extrapolated from small cell lung carcinoma. Reliable survival prediction tools are lacking.Methods: A total of 3,921 cases of EPSCC were collected from the Surveillance Epidemiology and End Results (SEER) database, which form the training and internal validation cohorts of the survival prediction model. The endpoint was an overall survival of 0.5–5 years. Internal validation performances of machine learning algorithms were compared, and the best model was selected. External validation (n = 68) was performed to evaluate the generalization ability of the selected model.Results: Among machine learning algorithms, the random forest model performs best on internal validation, whose area under the curve (AUC) is 0.736–0.800. The net benefit is higher than the TNM classification in decision curve analysis. The AUC of this model on the external validation cohort is 0.739–0.811. This model was then deployed online as a free, publicly available prediction tool of EPSCC (http://42.192.80.13:4399/).Conclusion: This study provides an excellent online survival prediction tool for EPSCC with machine learning and large-scale data. Age, TNM stages, and surgery (including potential performance status information) are the most critical factors for the prediction model.

21 December 2022 in Research Square
Verified
Preprint
Open access
PDF file
XZXin Zhang
Xin Zhang
PurposeExtrapulmonary small cell carcinoma (EPSCC) is rare, and its knowledge is mainly extrapolated from small cell lung carcinoma. Reliable survival prediction tools are lacking.Methods7813 cases of EPSCC were collected from the Surveillance Epidemiology and End Results (SEER) database as the train and internal validation cohort of the survival prediction model. The endpoints were overall survivals of 0.5-5 years. Internal validation performances of machine learning algorithms were compared, and the best model was selected. External validation was performed to evaluate the generalization ability of the selected model.ResultsAmong machine learning algorithms, the random forest model performs best on internal validation, whose area under the curve (AUC) is 0.734-0.811. The net benefit is higher than the TNM classification in decision curve analysis. The AUC of this model on the external validation cohort is 0.779-0.823. This model was then deployed online as a free, publicly available prediction tool of EPSCC. (http://42.192.80.13:4399/).ConclusionsThis study provides a well-performed online survival prediction tool for EPSCC with machine learning and large-scale data.